Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
説明 | Omarigliptin (MK-3102) has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency. |
ターゲット&IC50 | DPP4:1.6 nM |
別名 | MK-3102 |
分子量 | 398.43 |
分子式 | C17H20F2N4O3S |
CAS No. | 1226781-44-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (125.49 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Omarigliptin 1226781-44-7 Proteases/Proteasome Ubiquitination DPP-4 Proteasome MK-3102 inhibit glucagon like peptide-1 anti-parkinsonian Dipeptidyl Peptidase blood-brain barrier MK 3102 DPP orally active Inhibitor MK3102 anti-diabetic inhibitor